A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors.
暂无分享,去创建一个
Sebastian Schneeweiss | Daniel H Solomon | Robert J Glynn | Jerry Avorn | J. Avorn | S. Schneeweiss | R. Glynn | D. Solomon
[1] J. Concato,et al. Are preferences for cyclooxygenase-2 inhibitors influenced by the certainty effect? , 2004, The Journal of rheumatology.
[2] J. Avorn,et al. Determinants of selective cyclooxygenase-2 inhibitor prescribing: are patient or physician characteristics more important? , 2003, The American journal of medicine.
[3] M. Schemper. Predictive accuracy and explained variation , 2003, Statistics in medicine.
[4] B. Spiegel,et al. The Cost-Effectiveness of Cyclooxygenase-2 Selective Inhibitors in the Management of Chronic Arthritis , 2003, Annals of Internal Medicine.
[5] Mark Zezza,et al. Health spending projections for 2002-2012. , 2003, Health affairs.
[6] W. White,et al. Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis. , 2002, The American journal of cardiology.
[7] C Michael Stein,et al. COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease , 2002, The Lancet.
[8] M Maclure,et al. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. , 2001, American journal of epidemiology.
[9] R Day,et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. , 2000, The New England journal of medicine.
[10] P. Gøtzsche,et al. Non-steroidal anti-inflammatory drugs , 2000, BMJ : British Medical Journal.
[11] S. Menard. Coefficients of Determination for Multiple Logistic Regression Analysis , 2000 .
[12] Thomas J. Schnitzer,et al. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update , 2000 .
[13] A. Ash,et al. R2: a useful measure of model performance when predicting a dichotomous outcome. , 1999, Statistics in medicine.
[14] F. Lanza. A guideline for the treatment and prevention of NSAID-induced ulcers , 1998, American Journal of Gastroenterology.
[15] C A Gatsonis,et al. Variations in the Utilization of Coronary Angiography for Elderly Patients with an Acute Myocardial Infarction: An Analysis Using Hierarchical Logistic Regression , 1995, Medical care.
[16] R. Deyo,et al. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.
[17] N. Nagelkerke,et al. A note on a general definition of the coefficient of determination , 1991 .
[18] D. Hosmer,et al. Applied Logistic Regression , 1991 .